{{Rsnum
|rsid=5761268
|Gene=MYO18B
|Chromosome=22
|position=25843883
|Orientation=plus
|ReferenceAllele=C
|MissenseAllele=A
|GMAF=0.27
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=MYO18B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 47.8 | 42.5 | 9.7
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 23.8 | 49.0 | 27.2
| ASW | 29.8 | 45.6 | 24.6
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 62.4 | 34.7 | 3.0
| LWK | 15.5 | 53.6 | 30.9
| MEX | 70.7 | 27.6 | 1.7
| MKK | 9.7 | 52.3 | 38.1
| TSI | 43.1 | 43.1 | 13.7
| HapMapRevision=28
}}

{{Venter SNP
|rsid=5761268
|allele=A
|frequency=0.7
|uid=1103691019489
|type=homozygous_SNP
|hugo=MYO18B
|ensembl gene=ENSG00000133454
|ensembl transcript=ENST00000335473
|sift=TOLERATED
|disease=Defects in MYO18B are associated with lung cancer. Inactivated in half of the primary lung cancers and cell lines; the causes include deletions, mutations and promoter methylation.
}}

{{GET Evidence
|gene=MYO18B
|aa_change=His1119Gln
|aa_change_short=H1119Q
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs5761268
|overall_frequency_n=6404
|overall_frequency_d=9984
|overall_frequency=0.641426
|n_genomes=47
|n_genomes_annotated=0
|n_haplomes=67
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.001
|nblosum100=-1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}